Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
- Resource Type
- Article
- Source
- In
The Lancet Respiratory Medicine July 2018 6(7):511-525 - Subject
Primary Research Articles - Language
- ISSN
- 2213-2600